Seeking Alpha

Watson Pharmaceuticals (WPI -0.25%) sues the FDA for "improperly" denying the company's shared...

Watson Pharmaceuticals (WPI -0.25%) sues the FDA for "improperly" denying the company's shared exclusivity for a generic version of Type 2 diabetes drug Actos despite the firm following the agency's directions. As a result of the FDA's decision, Watson's abbreviated new drug application (ANDA) could be delayed for up to six months.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)